Sanofi India Limited (BOM: 500674)

Market Cap	169.79B
Revenue (ttm)	27.89B
Net Income (ttm)	5.29B
Shares Out	23.03M
EPS (ttm)	229.86
PE Ratio	32.11
Forward PE	n/a
Dividend	167.00 (2.27%)
Ex-Dividend Date	May 3, 2024

Volume	76
Open	7,310.05
Previous Close	7,319.90
Day's Range	7,310.05 - 7,490.15
52-Week Range	5,850.55 - 10,526.05
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Sanofi India

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through indepe...

• Industry: Pharmaceutical Preparations
• Founded: 1956
• Employees: 2,174
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500674

Financial Performance

In 2023, Sanofi India's revenue was 28.51 billion, an increase of 2.92% compared to the previous year's 27.70 billion. Earnings were 6.03 billion, a decrease of -2.85%.